1990 - Fellow of the American Association for the Advancement of Science (AAAS)
His Biochemistry study often links to related topics such as Cytotoxic T cell. His In vitro research extends to the thematically linked field of Cytotoxic T cell. In vitro and Cytotoxicity are commonly linked in his work. Alan C. Sartorelli integrates many fields in his works, including Cytotoxicity and DNA. He integrates DNA and DNA damage in his studies. His research is interdisciplinary, bridging the disciplines of Biochemistry and DNA damage. His Semicarbazone research extends to Stereochemistry, which is thematically connected. His Semicarbazone study frequently involves adjacent topics like Stereochemistry. In his works, Alan C. Sartorelli undertakes multidisciplinary study on Gene and Red blood cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Classification of Antineoplastic Agents by their Selective Toxicities toward Oxygenated and Hypoxic Tumor Cells
Beverly A. Teicher;John S. Lazo;Alan C. Sartorelli.
Cancer Research (1981)
The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes
Davide F Robbiani;Rick A Finch;Dirk Jäger;William A Muller.
Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity
Rick Avery Finch;Mao Chin Liu;Susan P. Grill;William C. Rose.
Biochemical Pharmacology (2000)
The hypoxic tumor cell: a target for selective cancer chemotherapy.
Katherine A. Kennedy;Beverly A. Teicher;Sara Rockwell;Alan C. Sartorelli.
Biochemical Pharmacology (1980)
Differentiation of immortal cells inhibits telomerase activity.
Harsh W. Sharma;John A. Sokoloski;Jose R. Perez;Jean Yves Maltese.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins.
Germana Rappa;Aurelio Lorico;Richard A. Flavell;Alan C. Sartorelli.
Cancer Research (1997)
Therapeutic attack of hypoxic cells of solid tumors: presidential address
Alan C. Sartorelli.
Cancer Research (1988)
Preferential Activation of Mitomycin C to Cytotoxic Metabolites by Hypoxic Tumor Cells
Katherine A. Kennedy;Sara Rockwell;Alan C. Sartorelli.
Cancer Research (1980)
Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione.
Aurelio Lorico;Germana Rappa;Rick A. Finch;Di Yang.
Cancer Research (1997)
Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer.
Joseph B. Weissberg;Yung H. Son;Rose J. Papac;Clarence Sasaki.
International Journal of Radiation Oncology Biology Physics (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: